Connect with us
In the first half of the year, Novo Nordisk saw significant growth in sales, with Ozempic revenue up 36% to 56.685 billion crowns (€7.596 billion) and...
BioNTech's revenues plummeted 78.1% in the first half of 2024, down to €316.3 million, due to decreased demand for Covid-19 vaccines and a seasonal sales lull....
According to the results presented by the pharmaceutical giants to the National Securities Commission (CNMV), the revenues of these five companies also rose in the first...
Córdoba Biotech Incubator specializes in biotechnology, offering three types of incubation: physical with labs, coworking, and virtual. It supports startups through tailored programs based on project...
Oryzon Genomics reported a loss of €2.4 million in the first half of 2024, slightly less than the €2.5 million loss in 2023. Financial losses decreased...
PharmaMar's turnover rose 0.8% in H1 2024, reaching €80.8 million, with oncology sales down 3.2%. Royalty income increased by 16%, while non-recurring income slightly declined. R&D...
Catalan start-up Made of Genes, specializing in personalized precision healthcare, plans to expand to the Middle East and the US. Already operating in Spain, Portugal, Andorra,...
Integra Therapeutics is a biotechnology company that creates genetic writing tools to improve the safety and efficacy of advanced therapies. The EC will invest in the...
Vytrus Biotech reported a 28% sales increase in H1 2024, reaching €2.5 million, with EBITDA rising 38% to nearly €1 million. The growth was driven by...
Moody's withdrew Grifols' ratings, citing "insufficient or inadequate" information amid a potential takeover by family shareholders and Brookfield fund. Grifols' shares dropped, with Class A down...